Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Agenus (AGEN) is a stock that can certainly grab the attention ...

There are many ways companies can manipulate their reported profits. Fudging sales (also known as revenue) is more difficult.

Hims & Hers Health is a top telehealth company with strong growth, innovation, and global expansion plans. See more on HIMS ...

Mutual of America Capital Management trimmed its CVS Health stake by 2.7% in Q1, now worth nearly $9.96 million. Several ...

Johnson & Johnson boosted its full-year outlook as it posted better-than-expected profit and sales in the second quarter. The chip-making equipment supplier, whose clients include Intel, issued a ...

SelectQuote’s undervaluation, rising recurring revenue, and margin gains position it well for FY25 despite recent volatility.

The offering, the first IPO this year, attracted more than 32 billion dirhams ($3.5 bln) in demand for 500 million dirhams in shares. GSK seeks FDA nod for expanded use of RSV vaccine in adults ...

Including the $706 million she disposed of in the first quarter, Safra Catz’s $2.5 billion total makes her the top insider ...

CVS Health (CVS - Free Report) has an Earnings ESP of +2.06% and a Zacks Rank #2 at present. The company is slated to release second-quarter 2025 results on July 31. You can see the complete list of ...

Eli Lilly (NYSE:LLY) drew attention on Friday after JPMorgan reiterated its bullish stance on the stock, raising its price ...

Fort Sheridan Advisors dramatically reduced its CVS Health stake by over 60%, selling 5,130 shares in the first quarter.